» Articles » PMID: 23741008

A Far Downstream Enhancer for Murine Bcl11b Controls Its T-cell Specific Expression

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2013 Jun 7
PMID 23741008
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Bcl11b is a T-cell specific gene in hematopoiesis that begins expression during T-lineage commitment and is required for this process. Aberrant expression of BCL11B or proto-oncogene translocation to the vicinity of BCL11B can be a contributing factor in human T-ALL. To identify the mechanism that controls its distinctive T-lineage expression, we corrected the identified Bcl11b transcription start site and mapped a cell-type-specific differentially methylated region bracketing the Bcl11b promoter. We identified a 1.9-kb region 850 kb downstream of Bcl11b, "Major Peak," distinguished by its dynamic histone marking pattern in development that mirrors the pattern at the Bcl11b promoter. Looping interactions between promoter-proximal elements including the differentially methylated region and downstream elements in the Major Peak are required to recapitulate the T-cell specific expression of Bcl11b in stable reporter assays. Functional dissection of the Major Peak sequence showed distinct subregions, in which TCF-1 sites and a conserved element were required for T-lineage-specific activation and silencing in non-T cells. A bacterial artificial chromosome encompassing the full Bcl11b gene still required the addition of the Major Peak to exhibit T-cell specific expression. Thus, promoter-proximal and Major Peak sequences are cis-regulatory elements that interact over 850 kb to control expression of Bcl11b in hematopoietic cells.

Citing Articles

Analysis of the Transcriptional Control of in Chicken: IRF1 and GATA1 as Negative Regulators.

Qiu L, Wang H, Li W, Yang T, Bai H, Chang G Animals (Basel). 2025; 15(5).

PMID: 40075948 PMC: 11898421. DOI: 10.3390/ani15050665.


A timed epigenetic switch balances T and ILC lineage proportions in the thymus.

Pease N, Denecke K, Chen L, Gerges P, Kueh H Development. 2024; 151(23.

PMID: 39655434 PMC: 11664168. DOI: 10.1242/dev.203016.


RNA-Independent Regulatory Functions of lncRNA in Complex Disease.

Kafida M, Karela M, Giakountis A Cancers (Basel). 2024; 16(15).

PMID: 39123456 PMC: 11311644. DOI: 10.3390/cancers16152728.


Super-enhancer omics in stem cell.

Ma H, Qu J, Pang Z, Luo J, Yan M, Xu W Mol Cancer. 2024; 23(1):153.

PMID: 39090713 PMC: 11293198. DOI: 10.1186/s12943-024-02066-z.


Epigenetic reprogramming of T cells: unlocking new avenues for cancer immunotherapy.

Singh V, Nandi S, Ghosh A, Adhikary S, Mukherjee S, Roy S Cancer Metastasis Rev. 2024; 43(1):175-195.

PMID: 38233727 DOI: 10.1007/s10555-024-10167-w.


References
1.
Nagel S, Scherr M, Kel A, Hornischer K, Crawford G, Kaufmann M . Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1. Cancer Res. 2007; 67(4):1461-71. DOI: 10.1158/0008-5472.CAN-06-2615. View

2.
Gottgens B, Broccardo C, Sanchez M, Deveaux S, Murphy G, Gothert J . The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1. Mol Cell Biol. 2004; 24(5):1870-83. PMC: 350551. DOI: 10.1128/MCB.24.5.1870-1883.2004. View

3.
Germar K, Dose M, Konstantinou T, Zhang J, Wang H, Lobry C . T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proc Natl Acad Sci U S A. 2011; 108(50):20060-5. PMC: 3250146. DOI: 10.1073/pnas.1110230108. View

4.
Su X, Della-Valle V, Andre-Schmutz I, Lemercier C, Radford-Weiss I, Ballerini P . HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32). Blood. 2006; 108(13):4198-201. DOI: 10.1182/blood-2006-07-032953. View

5.
Dekker J . The three 'C' s of chromosome conformation capture: controls, controls, controls. Nat Methods. 2005; 3(1):17-21. DOI: 10.1038/nmeth823. View